Aleafia Health Advances Cannabis as Medicine and Pursues R&D Opportunities, Cannabis vs Benzos

In this article:

NEW YORK, NY / ACCESSWIRE / January 29, 2019 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive report on Aleafia Health Inc. (OTCQX: ALEAF), a vertically integrated, Canadian national cannabis company, operates major medical clinic, cannabis cultivation and R&D facilities. A federally licensed producer and vendor of cannabis, the company has a planned and fully-funded annual production capacity of 98,000 kg of dried cannabis flower.

Aleafia operates medical cannabis clinics staffed by physicians and nurse practitioners, with over 50,000 patients. The company is highly differentiated, maintaining the largest medical cannabis dataset in the world. The company shares are also traded on the TSX Exchange under the symbol ALEF.

About the recent ALEAF cannabis vs benzodiazepine study and more in this full report READ MORE

Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/aleafia/

Experiential knowledge of medical cannabis therapy, a rapidly evolving science, helps ensure physicians make recommendations that have been proven effective through historical data, helping to avoid treatments based on trial and error. The company's staff of trained educators provide learning sessions for new patients, providing ongoing consultation ensuring patients are matched with the most appropriate treatment. Aleafia is based in Concord, Ontario.

ALEAF clinic, grow facilities, recent financial breakdown and more here: READ MORE

Copy and paste to your browser may be required to view the report - https://tradersnewssource.com/aleafia/

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit https://www.tradersnewssource.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

CONTACT:

editor@tradersnewssource.com

SOURCE: Traders News Source

Advertisement